NSJ Bioreagents

Melanoma Antibody / PNL2

Product Code:
 
NSJ-V3071IHC
Product Group:
 
Primary Antibodies
Supplier:
 
NSJ Bioreagents
Host Type:
 
Mouse
Antibody Isotype:
 
Mouse IgG1 kappa
Antibody Clonality:
 
Monoclonal
Antibody Clone:
 
PNL2
Regulatory Status:
 
RUO
Target Species:
 
Human
Application:
 
Immunohistochemistry- Paraffin Embedded (IHC-P)
Storage:
 
Store the Melanoma antibody PNL2 at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
1 / 2
IHC anlaylsis of formalin-fixed, paraffin-embedded human melanoma stained with Melanoma antibody (clone PNL2).~
2 / 2
SDS-PAGE Analysis of Purified, BSA-Free Melanoma Antibody (clone PNL2). Confirmation of Integrity and Purity of the Antibody.

IHC anlaylsis of formalin-fixed, paraffin-embedded human melanoma stained with Melanoma antibody (clone PNL2).~
SDS-PAGE Analysis of Purified, BSA-Free Melanoma Antibody (clone PNL2). Confirmation of Integrity and Purity of the Antibody.

No additional charges, what you see is what you pay! *

CodeSizePrice
NSJ-V3071IHC-7ML7 ml£534.00
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • Show All

Further Information

Application Details:
The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
Application Note:
Optimal dilution of the Melanoma antibody PNL2 should be determined by the researcher.

1. Staining of formalin-fixed tissues requires boiling tissue sections in 10mM Citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 min.
2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.

Description:
Anti-PNL2 is a novel melanoma marker monoclonal antibody, which has recently been introduced as an immunohistochemical reagent to stain melanocytes and tumors derived therefrom. The antigen recognized by PNL2 is different from Melan A and gp100. Its epitope is not destroyed by digestion with neuraminidase i.e. its epitope is not glycosylated. Anti-PNL2 may be most useful because of its high sensitivity for metastatic melanoma (87%), as opposed to 76% for anti-HMB45 and 82% for anti-MART-1. Anti-PNL2 labels intra-epidermal nevi while the dermal component of compound nevi are largely non-reactive with anti-PNL2. Antibodies against PNL2, MART-1 (Melan A) and HMB45 stain most clear cell sarcoma cells and a few cells in angiomyolipomas and lymphangioleiomyomatosis. Anti-PNL2 is a useful antibody for the identification of melanomas and clear cell sarcomas. Differential diagnosis is aided by the results from a panel of antibodies, including antibodies against HMB45, MART-1, tyrosinase, and MiTF.
Format:
Purified
Formulation:
Prediluted in 1X PBS with 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide; *For IHC use only*
Immunogen:
Melanocyte antigen was used as the immunogen for the Melanoma antibody PNL2.
Limitation:
This Melanoma antibody PNL2 is available for research use only.
Localization:
Cytoplasmic
Purity:
Protein G affinity chromatography

Documents